Brief: Oncoarendi Therapeutics Signs Deal With Biomapas For Clinical Study On OATD-02

Molecure SA

07/02/2022 14:11

Feb 7 (Reuters) - Oncoarendi Therapeutics SA  OAT.WA :
    * SIGNS DEAL WITH BIOMAPAS FOR ORGANISING AND CARRYING OUT
CLINICAL STUDY FOR  OATD-02
    * DEAL VALUE FOR BIOMAPAS AT ABOUT EUR 2.9 MILLION

Source text for Eikon:  ID:nEM7bTfwka 
Further company coverage:  OAT.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))